Genoil Inc. Files 6-K for June 30, 2024 Period
Ticker: GNOLF · Form: 6-K · Filed: Aug 15, 2024 · CIK: 1261002
| Field | Detail |
|---|---|
| Company | Genoil INC (GNOLF) |
| Form Type | 6-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, corporate-update
TL;DR
Genoil Inc. filed its Q2 2024 6-K, confirming 20-F annual report filings.
AI Summary
Genoil Inc. filed a Form 6-K for the period ending June 30, 2024. The filing, submitted on August 15, 2024, indicates that Genoil Inc. is a foreign private issuer and will file annual reports under Form 20-F. The company's principal executive office is located at One Rockefeller Plaza, 11th Floor, New York, NY.
Why It Matters
This filing provides an update on Genoil Inc.'s reporting status and corporate information as of June 30, 2024, which is important for investors tracking the company's regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine periodic filing (6-K) that primarily contains corporate information and does not appear to disclose significant new financial or operational developments.
Key Players & Entities
- GENOIL INC. (company) — Filer of the Form 6-K
- June 30, 2024 (date) — Period ending date for the report
- August 15, 2024 (date) — Filing date of the report
- Form 20-F (document) — Annual report form Genoil Inc. will file
- One Rockefeller Plaza, 11th Floor, New York, NY (location) — Principal executive office address
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information for the period ending June 30, 2024, as required by the U.S. Securities and Exchange Commission for foreign private issuers.
Which annual report form does Genoil Inc. indicate it will file?
Genoil Inc. indicates it will file annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of August 15, 2024.
Where is Genoil Inc.'s principal executive office located?
Genoil Inc.'s principal executive office is located at One Rockefeller Plaza, 11th Floor, New York, NY.
Is Genoil Inc. submitting this Form 6-K in paper format?
The filing indicates that Genoil Inc. is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
Filing Stats: 384 words · 2 min read · ~1 pages · Grade level 15.5 · Accepted 2024-08-15 06:02:39
Filing Documents
- gnolf_6k.htm (6-K) — 13KB
- gnolf_ex991.htm (EX-99.1) — 347KB
- 0001654954-24-010688.txt ( ) — 361KB
Financial Statements
Financial Statements 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Genoil Inc. (Registrant) Date: August 14, 2024 By: /s/ David Lifschultz Name: David Lifschultz Title: CEO 3